(Q36327362)

13 August 2017

1 reference

title

Antigen-specific induction of regulatory T cells for type 1 diabetes therapy (English)

1 reference

13 August 2017

0 references

3

Matthias von Herrath

1 reference

13 August 2017

Christophe Filippi

1

1 reference

13 August 2017

Damien Bresson

series ordinal

2

1 reference

13 August 2017

publication date

1 September 2005

1 reference

International Reviews of Immunology

13 August 2017

published in

1 reference

13 August 2017

volume

24

1 reference

13 August 2017

issue

5-6

1 reference

13 August 2017

page(s)

341-360

1 reference

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Control of T-cell activation by CD4+ CD25+ suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

An essential role for Scurfin in CD4+CD25+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Regulatory T cells and intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Foxp3 and natural regulatory T cells: key to a cell lineage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Transforming growth factor-beta in T-cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Multiple immuno-regulatory defects in type-1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

DNA immunization to prevent autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Suppression of autoimmune diabetes by viral IL-10 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Effects of insulin in relatives of patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Introducing baselines for therapeutic use of regulatory T cells and cytokines in autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Peripheral tolerance of CD8 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Antigen-induced regulatory T cells in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371116

T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors.

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1096/FJ.02-1139FJE

Identifiers

DOI

10.1080/08830180500371116

1 reference

13 August 2017

1 reference